Trial reportBrain and cognition2025
Aerobic walking exercise training boosts thalamic connectivity in MS patients with cognitive processing speed impairment.
Trial report in Brain and cognition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The effects of Nordic walking on cognitive function in older adults: a systematic review and meta-analysis.Frontiers in aging neuroscience · 2025Pooled it
- Thalamocortical connectivity associated with fatigue after accounting for depressive symptoms in stroke survivors and controls.NeuroImage. Clinical · 2026Article
- Preventive strategies in neuroimmunology.Neurological research and practice · 2026Review
- Feasibility of a 12-month, remotely delivered and supported aerobic walking exercise training program for brain and cognition in adults with multiple sclerosis.Journal of neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThe current study involved a single-blind, randomized controlled trial on the effects of aerobic treadmill walking exercise training compared with an active control condition as an approach to modify thalamocortical resting-state functional connectivity (RSFC) as a neurobiological correlate of cognitive processing speed (CPS) impairment in 28 fully-ambulatory persons with multiple sclerosis (MS) who were pre-screened for impaired CPS.
methodsParticipants completed baseline assessments of CPS and underwent resting-state fMRI to measure thalamocortical RSFC. Following baseline, participants were randomly assigned into either 12-weeks of supervised, aerobic treadmill walking exercise training or 12-weeks of stretching and range-of-motion activities (active control condition). After the 12-week study period, participants underwent follow-up assessments of CPS and thalamocortical RSFC using a treatment-blinded assessor.
resultsAerobic treadmill walking exercise training was associated with significantly increased RSFC between the thalamus and frontal/parietal regions relative to the active control condition. By comparison, the active control condition was associated with significantly increased RSFC between the thalamus and occipital regions relative to the treadmill condition.
conclusionsThe current RCT provides critical information on underlying neurophysiological mechanisms of aerobic treadmill walking exercise training and stretching and range-of-motion activities among fully-ambulatory, but CPS impaired persons with MS. This is important for informing the design of aerobic exercise programs that selectively target thalamocortical RSFC as an approach to improve CPS in persons with MS. Such programs may be ripe for inclusion in a future mechanistic trial focusing on thalamocortical RSFC as a mediator of exercise effects on CPS in MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.